APA

Kuwana M., Blair C., Takahashi T., Langley J. & Coghlan J. G. (20200707). Initial combination therapy of ambrisentan and tadalafil in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH) in the modified intention-to-treat population of the AMBITION study: post hoc analysis. : Annals of the rheumatic diseases.

Chicago

Kuwana Masataka, Blair Christiana, Takahashi Tomohiko, Langley Jonathan and Coghlan John G. 20200707. Initial combination therapy of ambrisentan and tadalafil in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH) in the modified intention-to-treat population of the AMBITION study: post hoc analysis. : Annals of the rheumatic diseases.

Harvard

Kuwana M., Blair C., Takahashi T., Langley J. and Coghlan J. G. (20200707). Initial combination therapy of ambrisentan and tadalafil in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH) in the modified intention-to-treat population of the AMBITION study: post hoc analysis. : Annals of the rheumatic diseases.

MLA

Kuwana Masataka, Blair Christiana, Takahashi Tomohiko, Langley Jonathan and Coghlan John G. Initial combination therapy of ambrisentan and tadalafil in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH) in the modified intention-to-treat population of the AMBITION study: post hoc analysis. : Annals of the rheumatic diseases. 20200707.